Milk Protein Fragments Blocked Influenza Virus at Incredibly Low Concentrations

Researchers split bovine lactoferrin into its N-lobe and C-lobe and tested each against multiple influenza subtypes. Far-western blotting and sequencing identified the viral binding site. Molecular docking studies were used to identify the most active peptide fragments from the C-lobe. Antiviral activity was measured by hemagglutination inhibition and cell infection assays using cultured cells.

Influenza viruses mutate rapidly, making vaccines a yearly gamble and creating demand for broad-spectrum antivirals. These lactoferrin fragments target the fusion peptide — one of the most conserved parts of the virus that cannot easily mutate without losing function. Finding antiviral peptides that work at femtomolar concentrations against multiple flu subtypes is remarkable and could lead to new therapeutic approaches, especially during pandemic influenza strains.

This study adds to the growing body of evidence that natural antimicrobial proteins — particularly those found in milk — contain peptide fragments with potent antiviral properties. Lactoferrin-derived peptides are being explored not just against influenza but against a range of viruses including SARS-CoV-2, HIV, and hepatitis. The femtomolar potency reported here is exceptional and, if confirmed in animal models, could position these fragments among the most potent peptide antivirals known.

All experiments were conducted in vitro (cell culture and molecular modeling), not in animals or humans. Femtomolar potency in a test tube may not translate to in vivo efficacy due to peptide degradation, bioavailability challenges, and the complexity of actual infection. The study does not address toxicity, pharmacokinetics, or route of administration. Independent replication of the femtomolar potency claim would strengthen confidence in these findings.